EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Biological Evaluation of New Chalcogen Semicarbazone ( S , Se ) and Their Azole Derivatives against Chagas Disease

Mercedes Rubio-Hernández iD, Verónica Alcolea, Elany Barbosa da Silva iD, Miriam A Giardini iD, Thaís H M Fernandes iD, Nuria Martínez-Sáez iD, Anthony J O'Donoghue, Jair L Siqueira-Neto, Silvia Pérez-Silanes iD

Journal of Medicinal Chemistry · 14.11.2024 · 67 (21) · 19038-19056

DOI: 10.1021/acs.jmedchem.4c01535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.11.2024. Verfasst von Mercedes Rubio-Hernández und 8 weiteren Autor:innen. Beteiligte Einrichtung: ISTUN Institute of Tropical Health, Department of Pharmaceutical Sciences, Universidad de Navarra, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Semicarbazones, Trypanocidal Agents, Chagas Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, bill and melinda gates, Departamento de Educaci?n, Gobierno de Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease is caused by the eukaryote parasite Trypanosoma cruzi. Current treatment exhibits limited efficacy and selenium-based compounds emerged as promising candidates for new therapies which is surpassing its bioisoster, sulfur. We designed new thiosemicarbazones, thiazoles, selenosemicarbazones and selenazoles, using isosteric substitution. We synthesized 57 new chalcogen compounds which were evaluated against T. cruzi, C2C12 cells and cruzain, the main target of this parasite. Additionally, human cathepsin L, was tested for selectivity. Three compounds were selected, based on their activity against the intracellular amastigotes (EC50 10) and cruzain (IC50 5.55) which compared favorably with the approved drug, Benznidazole, and the well-established cruzain inhibitor K777. Seleno-compounds demonstrated enhanced activity and selenazoles showed a decrease in selenium-associated toxicity. Compound 4-methyl-2-(2-(1-(3-nitrophenyl)ethylidene)hydrazineyl)-1,3-selenazole (Se2h) emerged as a promising candidate, and its binding to cruzain was investigated. Pharmacokinetic assessment was conducted, showing a favorable profile for subsequent in vivo assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziSemicarbazonesTrypanocidal AgentsChagas DiseaseAzolesHumansAnimalsMiceStructure-Activity RelationshipChalcogensCell LineCathepsin LOrganoselenium CompoundsProtozoan Proteins

Substanzen

SemicarbazonesTrypanocidal AgentsAzolesChalcogensCathepsin LOrganoselenium CompoundsProtozoan Proteins

Autor:innen und Institutionen

  • ISTUN Institute of Tropical Health, Department of Pharmaceutical Sciences, Universidad de Navarra, 31008 Pamplona, Spain.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences and Center for Discovery and Innovation in Parasitic Diseases, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
  • Department of Pharmaceutical Sciences, Universidad de Navarra, 31008 Pamplona, Spain.

ORCID-Profile: Mercedes Rubio-Hernández, Elany Barbosa da Silva, Miriam A Giardini, Thaís H M Fernandes, Nuria Martínez-Sáez, Silvia Pérez-Silanes

Förderung

  • NIAID NIH HHS
  • bill and melinda gates
  • Departamento de Educaci?n, Gobierno de Navarra
  • Bill and Melinda Gates Foundation
  • National Institutes of Health
  • Universidad de Navarra
  • Spanish Ministry of Education

Zitieren

APA

Rubio-Hernández, M., Alcolea, V., Barbosa da Silva, E., Giardini, M. A., M Fernandes, T. H., Martínez-Sáez, N., O'Donoghue, A. J., Siqueira-Neto, J. L., & Pérez-Silanes, S. (2024). Synthesis and Biological Evaluation of New Chalcogen Semicarbazone ( S , Se ) and Their Azole Derivatives against Chagas Disease. Journal of Medicinal Chemistry, 67(21), 19038-19056. https://doi.org/10.1021/acs.jmedchem.4c01535

Vancouver

Rubio-Hernández M, Alcolea V, Barbosa da Silva E, Giardini MA, M Fernandes TH, Martínez-Sáez N, et al. Synthesis and Biological Evaluation of New Chalcogen Semicarbazone ( S , Se ) and Their Azole Derivatives against Chagas Disease. Journal of Medicinal Chemistry. 2024;67(21):19038-19056. doi:10.1021/acs.jmedchem.4c01535

BibTeX
@article{RubioHernndez2024,
  author = {Rubio-Hernández, Mercedes and Alcolea, Verónica and Barbosa da Silva, Elany and Giardini, Miriam A and M Fernandes, Thaís H and Martínez-Sáez, Nuria and O'Donoghue, Anthony J and Siqueira-Neto, Jair L and Pérez-Silanes, Silvia},
  title = {Synthesis and Biological Evaluation of New Chalcogen Semicarbazone ( S , Se ) and Their Azole Derivatives against Chagas Disease},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {21},
  pages = {19038--19056},
  doi = {10.1021/acs.jmedchem.4c01535}
}
Kostenlos starten →